Skip to main content

Bristol Myers Squibb cash flow statement

  • BMY · NYSE
  • Pharmaceuticals
  • S&P 500
$63.43+1.78%Close 13 Nov 2026 · Market value $128.9B

In fiscal 2025 (the year to 31 Dec 2025), Bristol Myers Squibb generated $14.16B of operating cash flow and $12.85B of free cash flow, after $1.31B of capital expenditure.

From Bristol Myers Squibb's annual and quarterly reports, each period checked against accounting identities; a figure that does not pass is left blank. Fiscal years follow the company's calendar, the latest ending 31 Dec 2025. TTM is the last four reported quarters added up.

Annual

Bristol Myers Squibb cash flow statement, annual
USDFY 2007FY 2008FY 2009FY 2010FY 2011FY 2012FY 2013FY 2014FY 2015FY 2016FY 2017FY 2018FY 2019FY 2020FY 2021FY 2022FY 2023FY 2024FY 2025TTM
Net income$2.17B$5.25B$10.61B$3.10B$3.71B$1.96B$2.56B$2.00B$1.56B$4.46B$1.01B$4.92B$3.44B−$9.02B$6.99B$6.33B$8.03B−$8.95B$7.05B$9.24B
Depreciation & amortization$542.0M$562.0M$469.0M$607.0M$628.0M$681.0M$1.62B$467.0M$376.0M$382.0M$789.0M$637.0M$1.75B$10.38B$10.69B$10.28B$9.76B$9.60B$4.01B$2.82B
Stock-based compensation$133.0M$181.0M$183.0M$193.0M$161.0M$154.0M$191.0M$213.0M$235.0M$205.0M$199.0M$221.0M$441.0M$779.0M$583.0M$457.0M$518.0M$507.0M$553.0M$552.0M
Operating cash flow$3.15B$3.71B$4.07B$4.49B$4.84B$6.94B$3.54B$3.15B$2.10B$3.06B$5.28B$7.07B$8.21B$14.05B$16.21B$13.07B$13.86B$15.19B$14.16B$10.65B
Operating cash flow margin20.2%20.9%21.6%23.0%22.8%39.4%21.6%19.8%12.7%15.7%25.4%31.3%31.4%33.0%34.9%28.3%30.8%31.4%29.4%21.3%
Capital expenditures$843.0M$941.0M$730.0M$424.0M$367.0M$548.0M$537.0M$526.0M$820.0M$1.22B$1.05B$951.0M$836.0M$753.0M$973.0M$1.12B$1.21B$1.25B$1.31B$1.37B
Acquisitions$432.0M$191.0M$2.23B$829.0M$360.0M$7.53B—$219.0M$1.11B$359.0M$726.0M$2.37B$24.78B$13.08B$1.61B$4.29B$1.17B$21.82B$3.94B$2.98B
Free cash flow$2.31B$2.77B$3.33B$4.07B$4.47B$6.39B$3.01B$2.62B$1.28B$1.84B$4.22B$6.12B$7.37B$13.30B$15.23B$11.95B$12.65B$13.94B$12.85B$9.29B
Free cash flow margin14.8%15.6%17.7%20.9%21.1%36.3%18.4%16.5%7.8%9.5%20.3%27.1%28.2%31.3%32.8%25.9%28.1%28.9%26.7%18.6%
Free cash flow per share$1.16$1.38$1.69$2.35$2.61$3.79$1.81$1.57$0.77$1.10$2.55$3.74$4.31$5.89$6.79$5.57$6.09$6.88$6.30$4.54
Dividends paid$2.21B$2.46B$2.48B$2.20B$2.25B$2.29B$2.31B$2.40B$2.48B$2.55B$2.58B$2.61B$2.68B$4.08B$4.40B$4.63B$4.74B$4.86B$5.04B$5.12B
Gross share repurchases———$576.0M$1.22B$2.40B$433.0M——$231.0M$2.47B$320.0M$7.30B$1.55B$6.29B$8.00B$5.16B$0.00$0.00—
Stock issuance proceeds——$45.00M$252.0M$601.0M$463.0M$564.0M$288.0M$266.0M$181.0M——————————
Net share repurchases——−$45.00M$324.0M$620.0M$1.94B−$131.0M−$288.0M−$266.0M$50.00M$2.47B$320.0M$7.30B$1.55B$6.29B$8.00B$5.16B$0.00$0.00—
Cash interest paid—$303.0M$206.0M$178.0M$171.0M$241.0M$268.0M$238.0M$205.0M$191.0M$221.0M$218.0M$414.0M$1.60B$1.50B$1.40B$1.20B$1.80B$2.10B$1.70B
Free cash flow after SBC$2.18B$2.58B$3.15B$3.87B$4.31B$6.24B$2.82B$2.41B$1.05B$1.64B$4.02B$5.89B$6.93B$12.52B$14.65B$11.49B$12.13B$13.44B$12.29B$8.73B

Quarterly

Bristol Myers Squibb cash flow statement, quarterly
USDQ4 FY2023Q1 FY2024Q2 FY2024Q3 FY2024Q4 FY2024Q1 FY2025Q2 FY2025Q3 FY2025Q4 FY2025Q1 FY2026Q2 FY2026Q3 FY2026
Net income$1.76B−$11.91B$1.68B$1.21B$72.00M$2.46B$1.31B$2.20B$1.09B$2.68B$3.32B$2.16B
Depreciation & amortization$2.46B$2.53B$2.56B$2.57B$1.88B$1.01B$1.03B$1.03B$977.0M$594.0M$610.0M$642.0M
Stock-based compensation$127.0M$133.0M$125.0M$129.0M$120.0M$144.0M$137.0M$139.0M$133.0M$146.0M$135.0M$138.0M
Operating cash flow$4.25B$2.83B$2.33B$5.59B$4.44B$1.95B$3.92B$6.31B$1.97B$1.10B$3.39B$4.18B
Operating cash flow margin37.0%23.9%19.1%47.0%36.0%17.4%31.9%51.6%15.8%9.6%26.2%32.0%
Capital expenditures$330.0M$284.0M$262.0M$324.0M$378.0M$260.0M$361.0M$320.0M$370.0M$347.0M$305.0M$344.0M
Acquisitions$581.0M$20.05B$1.37B$348.0M$47.00M$78.00M$285.0M$1.87B$1.71B$65.00M$91.00M$1.11B
Free cash flow$3.92B$2.55B$2.06B$5.27B$4.06B$1.69B$3.56B$5.99B$1.60B$757.0M$3.09B$3.84B
Free cash flow margin34.2%21.5%16.9%44.3%32.9%15.1%29.0%49.0%12.8%6.6%23.8%29.4%
Free cash flow per share$1.93$1.26$1.02$2.59$2.00$0.83$1.74$2.94$0.79$0.37$1.51$1.87
Dividends paid$1.16B$1.21B$1.22B$1.22B$1.22B$1.26B$1.26B$1.26B$1.26B$1.28B$1.29B$1.29B
Gross share repurchases$0.00$0.00$0.00$0.00$0.00———————
Net share repurchases$0.00$0.00$0.00$0.00$0.00———————
Cash interest paid$268.0M$308.0M$427.0M$665.0M$400.0M$624.0M$376.0M$700.0M$400.0M$473.0M$316.0M$511.0M
Free cash flow after SBC$3.79B$2.42B$1.94B$5.14B$3.94B$1.55B$3.42B$5.85B$1.47B$611.0M$2.95B$3.70B

The main figures as JSON and plain text. See data and methodology.

BMY in the terminal

Every line back twenty years, charts of any figure, segments and KPIs by quarter, valuation and alerts.